Complicated Intra-Abdominal Infections Global Clinical Trials Review, H1, 2017

2017-06-30
Price :
Published : Jun-2017
No. of Pages : 90
order by fax Inquire before Buying request discount
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Complicated Intra-Abdominal Infections to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Complicated Intra-Abdominal Infections to Infectious Disease Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Complicated Intra-Abdominal Infections Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Complicated Intra-Abdominal Infections 39
Apr 19, 2017: Merck to Present Data on ZERBAXA at ECCMID 2017 39
Clinical Trial Profile Snapshots 40
Appendix 88
Abbreviations 88
Definitions 88
Research Methodology 89
Secondary Research 89
About GlobalData 90
Contact Us 90
Source 90

List of Tables
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials by Region, 2017* 8
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
Proportion of Complicated Intra-Abdominal Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 18
Complicated Intra-Abdominal Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Complicated Intra-Abdominal Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 21
Proportion of Complicated Intra-Abdominal Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 23
Complicated Intra-Abdominal Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Complicated Intra-Abdominal Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials by Phase, 2017* 26
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Complicated Intra-Abdominal Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38

List of Figures
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
Proportion of Complicated Intra-Abdominal Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 17
Complicated Intra-Abdominal Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Complicated Intra-Abdominal Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Complicated Intra-Abdominal Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 22
Complicated Intra-Abdominal Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Complicated Intra-Abdominal Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
Complicated Intra-Abdominal Infections Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Complicated Intra-Abdominal Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Complicated Intra-Abdominal Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
GlobalData Methodology 89
Filed in: Pharmaceutical
Publisher : GlobalData